Carr, Molly C.

The Emergence of the Metabolic Syndrome with Menopause

Carr, M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism

Menopause: Health Impacts and TreatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,449

Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.

Carr, M. C., & Brunzell, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

Cited by 493

Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender and diet.

Deeb, S. S., Zambon, A., Carr, M. C., Ayyobi, A. F., & Brunzell, J. D. (2003) · Journal of Lipid Research

Lipid metabolism and disordersParaoxonase enzyme and polymorphisms

Cited by 193

Impact of a weekly glucagon-like peptide 1 receptor agonist, albiglutide, on glycemic control and on reducing prandial insulin use in type 2 diabetes inadequately controlled on multiple insulin therapy: a randomized trial.

Rosenstock, J., Nino, A., Soffer, J., Erskine, L., Acusta, A., Dole, J., Carr, M. C., Mallory, J., & Home, P. (2020) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 73

Effect of raloxifene on serum triglycerides in women with a history of hypertriglyceridemia while on oral estrogen therapy.

Carr, M. C., Knopp, R. H., Brunzell, J. D., Wheeler, B. S., Zhu, X., Lakshmanan, M., Rosen, A. S., & Anderson, P. W. (2005) · Diabetes Care

Menopause: Health Impacts and TreatmentsLipoproteins and Cardiovascular Health

Cited by 22